Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$9.01 - $12.01 $382,925 - $510,425
42,500 New
42,500 $383,000
Q3 2021

Nov 15, 2021

SELL
$9.01 - $12.01 $718,097 - $957,197
-79,700 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$10.17 - $12.64 $810,549 - $1.01 Million
79,700 New
79,700 $954,000
Q4 2020

Feb 16, 2021

SELL
$9.23 - $18.18 $138,450 - $272,700
-15,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$9.38 - $12.48 $23,450 - $31,200
-2,500 Reduced 14.29%
15,000 $142,000
Q2 2019

Aug 14, 2019

BUY
$8.75 - $13.03 $153,125 - $228,025
17,500 New
17,500 $188,000
Q1 2019

May 15, 2019

SELL
$7.72 - $12.81 $463,200 - $768,600
-60,000 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$13.05 - $19.05 $195,750 - $285,750
-15,000 Reduced 20.0%
60,000 $1.02 Million
Q2 2018

Aug 14, 2018

BUY
$13.9 - $19.8 $1.04 Million - $1.49 Million
75,000 New
75,000 $1.07 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $135M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.